Long noncoding RNA and mRNA profiling in cetuximab‐resistant colorectal cancer cells by RNA sequencing analysis

Citations Over TimeTop 14% of 2019 papers

Abstract

To gain an insight into the molecular mechanisms of cetuximab resistance in colorectal cancer, we generated a cetuximab-resistant cell line (H508/CR) and performed RNA sequencing to identify the differential expression patterns of noncoding RNAs (ncRNAs) and mRNAs between cetuximab-sensitive and resistant cells. A total of 278 ncRNA transcripts and 1,059 mRNA transcripts were dysregulated in the cetuximab-resistant cells. The expression levels of nine selected long noncoding RNAs (lncRNAs) were validated using quantitative real-time PCR. Functional analysis revealed that several groups of lncRNAs might be involved in pathways associated with cetuximab resistance. Increased glucose consumption and lactate secretion in cetuximab-resistant cells suggested that glucose metabolism might be involved in cetuximab resistance. In addition, lncRNA LINC00973 was upregulated in the H508/CR cell line and cells transfected with a LINC00973 short interfering RNA exhibited reduced cell viability, increased apoptosis, and decreased glucose consumption and lactate secretion. Our results provide essential data regarding differentially expressed lncRNAs and mRNAs in cetuximab-resistant cells, which may provide new potential candidates for cetuximab therapy.

Related Papers

• → Circulating MicroRNA and Long Noncoding RNA as Biomarkers of Cardiovascular Diseases(2015)68 cited
• → Long Noncoding RNAs in Metabolic Syndrome Related Disorders(2016)76 cited
• → Short Interfering RNA (siRNA)—Mediated RNA Interference (RNAi) in Human Cells(2003)82 cited
• → Can siRNA Technology Provide the Tools for Gene Therapy of the Future?(2006)34 cited
• The dichotomy of p53 regulation by noncoding RNAs(2014)